Current management strategy of hepatocellular carcinoma
Authors:
- Bernardino RamponeBRBernardino Rampone
- Beniamino SchiavoneBSBeniamino Schiavone
- Antonio MartinoAMAntonio Martino
- Carmine VivianoCVCarmine Viviano
- Giuseppe ConfuortoGCGiuseppe Confuorto
Open Access
- 1 January 2009
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 15 (26) , 3210-3216
Abstract
Current management strategy of hepatocellular carcinomaKeywords
This publication has 82 references indexed in Scilit:
- Molecular targeted therapies in hepatocellular carcinoma†Hepatology, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Prospective validation of the Barcelona Clinic Liver Cancer staging systemJournal of Hepatology, 2006
- Liver transplantation for hepatocellular carcinoma: Lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policyLiver Transplantation, 2004
- Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infectionCancer, 2003
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Comparison of Surgical Outcomes for Hepatocellular Carcinoma in Patients With Hepatitis B Versus Hepatitis C: A Western ExperienceAnnals of Surgical Oncology, 2000
- Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysisCancer, 1990